The Beauty Health Company SKIN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 64.9%+8.3pp | 65.3%+10.8pp | 64.8%+14.3pp | 61.5%+28.1pp | 56.6%+18.6pp | |
| Operating margin | -3.6%+15.8pp | -7%+13.3pp | -9.3%+13.4pp | -14%+24.1pp | -19.5%+13.7pp | |
| Net margin | -2%+9.9pp | -3.2%+5.5pp | -3.9%+4.2pp | -6.1%+16.7pp | -11.9%+8.5pp | |
| EBITDA margin | 3.1%+14.3pp | -0%+11.4pp | -1.9%+11.3pp | -6.5%+22.8pp | -11.2%+13.3pp | |
| Free cash flow margin | 9.6%— | 12.4%— | 12.8%— | —— | —— | |
| Returns | ||||||
| Return on equity | -12%+58.5pp | -16.9%+35.5pp | -18.7%+18.9pp | -26.5%+45.9pp | -70.4%+4.2pp | |
| Return on assets | -1.1%+4.0pp | -1.6%+2.0pp | -2%+1.4pp | -3.1%+6.6pp | -5.1%+3.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.4×0.0× | |
| Inventory turnover | 1.8×+0.1× | 1.8×-0.1× | 1.6×-0.7× | 1.8×-0.9× | 1.7×-0.5× | |
| Liquidity | ||||||
| Current ratio | 1.8×-5.7× | 1.7×-5.3× | 5×-1.6× | 5.1×-1.3× | 7.5×+0.9× | |
| Quick ratio | 1.5×-4.9× | 1.4×-4.6× | 4.1×-1.5× | 4.2×-1.3× | 6.4×+0.9× | |
| Cash ratio | 1.3×-4.6× | 1.2×-4.2× | 3.5×-1.3× | 3.6×-1.1× | 5.9×+1.2× | |
| Leverage | ||||||
| Debt-to-equity | 2.3×+2.0× | 2.3×-8.7× | 5.8×+5.5× | 5.1×+4.8× | 0.3×0.0× | |
| Debt-to-assets | 0.3×+0.2× | 0.3×-0.6× | 0.8×+0.7× | 0.7×+0.7× | 0×0.0× | |
| Net debt / EBITDA | -8.6×— | —— | —— | —— | —— | |
| Interest coverage | -0.5×+5.9× | -1.1×+5.4× | -1.8×+5.2× | -3.7×+7.6× | -6.4×+3.5× | |
| Per Share | ||||||
| Book value per share | $0.42+14.1% | $0.45+23.7% | $0.52+7.5% | $0.53+8.2% | $0.37-15.9% | |
| Valuation | ||||||
| Market capitalization | $89.75M-63.3% | $177.23M-10.2% | $252.38M+41.7% | $241.91M+2.3% | $167.83M-70.6% | |
| Enterprise value | $11.24M-97.3% | $82.88M-79.0% | $411.97M+351% | $406.64M+523% | -$190.5M-231% | |
| Price / sales | 0.3×-0.5× | 0.6×0.0× | 0.8×+0.3× | 0.8×+0.1× | 0.5×-0.9× | |
| Price / book | 1.6×-1.7× | 2.9×-0.9× | 3.8×+0.9× | 3.3×-0.1× | 3.6×-5.4× | |
| EV / EBITDA | 1.2×— | —— | —— | —— | —— | |
| EV / sales | 0×-1.3× | 0.3×-0.9× | 1.4×+1.8× | 1.3×+1.6× | -0.6×-1.0× | |
| Free cash flow yield | 31.7%— | 21%— | 15.3%— | —— | —— | |
| Earnings yield | -6.7%+1.0pp | -5.4%+9.4pp | -4.7%+11.2pp | -7.9%+27.6pp | -22.9%-8.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are The Beauty Health Company's profit margins?
- The Beauty Health Company (SKIN) runs a 64.9% gross margin and a -3.6% operating margin, with a -2.0% net margin.
- Where do The Beauty Health Company's ratios come from?
- Every ratio is computed from The Beauty Health Company's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
